Buscar
Can Fite Biopharma Ltd
CANFAñadir a la lista de seguimiento
4.700USD
+1.730+58.25%
Cierre 07/01, 16:00（ET）Cotizaciones retrasadas 15 min
9.80MCap. mercado
PérdidaP/E TTM
Más Datos de Can Fite Biopharma Ltd Compañía
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Información de Can Fite Biopharma Ltd
Símbolo de cotizaciónCANF
Nombre de la empresaCan Fite Biopharma Ltd
Fecha de salida a bolsaSep 22, 2005
Director ejecutivoFishman (Pnina)
Número de empleados5
Tipo de seguridadDepository Receipt
Fin del año fiscalSep 22
Dirección10 Bareket Street, Kiryat Matalon
CiudadPETAH TIKVA
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísIsrael
Código postal49170
Teléfono97239241114
Sitio Webhttps://www.canfite.com/
Símbolo de cotizaciónCANF
Fecha de salida a bolsaSep 22, 2005
Director ejecutivoFishman (Pnina)
Ejecutivos de Can Fite Biopharma Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Yoseph Borenstein
Mr. Yoseph Borenstein
Director
Director
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Can Fite Biopharma Ltd?
Los cinco principales accionistas de Can Fite Biopharma Ltd son: Dr. Sari Fishman, Ph.D.
¿Cuántas instituciones poseen acciones de Can Fite Biopharma Ltd (CANF)?
A fecha de 2026Q1, 28 instituciones poseen acciones de Can Fite Biopharma Ltd, con un valor de mercado combinado de aproximadamente 32.13K, lo que representa el 1.50% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -81636.00.